Agios Pharmaceuticals, Inc.AGIONASDAQ
LOADING
|||
Switch Symbol:
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-391.53M
↓ 41% below average
Average (9y)
$-277.34M
Historical baseline
Range
High:$28.65M
Low:$-413.06M
CAGR
+16.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-391.53M | -31.8% |
| 2023 | $-297.06M | +5.5% |
| 2022 | $-314.36M | +23.9% |
| 2021 | $-413.06M | -35.5% |
| 2020 | $-304.87M | +20.4% |
| 2019 | $-382.79M | -22.9% |
| 2018 | $-311.41M | -7.4% |
| 2017 | $-289.86M | -1111.8% |
| 2016 | $28.65M | +129.5% |
| 2015 | $-97.11M | - |